MedTrace Logo

Evaluation of Ureteral Jets on Cystoscopy

NCT02476448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2019-10-23

Study results available
· View outcomes & findings →

Summary

This study evaluates 4 different methods to aid surgeons to visualize ureteral jets on cystoscopy.

Conditions

  • Injury of Ureter

Interventions

DRUG

Normal saline

Used to distend the bladder for cystoscopic evaluation

DRUG

Phenazopyridine

Administered orally preoperatively and assessed during cystoscopy

DRUG

Dextrose 10%

Used to distend the bladder for cystoscopic evaluation

DRUG

Sodium Fluorescein

Administered intravenously and assessed during cystoscopy

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER

  • Cecilia Calvo

    lead OTHER

Principal Investigators

  • Guillermo Davila, MD · Cleveland Clinic Florida

  • Alexandriah Alas, MD · Cleveland Clinic Florida

  • Luis M Espaillat, MD · Cleveland Clinic Florida

  • Eric A Hurtado, MD · Cleveland Clinic Florida

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02476448 on ClinicalTrials.gov